AAMU
DCPH

Amundi Asset Management US’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Amundi Asset Management US’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,200
Closed -$297K – 1581
2020
Q4 		$297K Hold
5,200
– – ﹤0.01% 1374
2020
Q3 		$267K Hold
5,200
– – ﹤0.01% 1345
2020
Q2 		$311K Hold
5,200
– – ﹤0.01% 1320
2020
Q1 		$214K Buy
+5,200
New +$289K ﹤0.01% 1323

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Amundi Asset Management US's DCPH Position: Q1 2021 in Review

Amundi Asset Management US sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2021, closing a stake of 5,200 shares — an estimated $297K sold.

Amundi Asset Management US first reported a position in DCPH in Q1 2020 and held it in 4 quarters. The position peaked at $311K in Q2 2020. 168 funds tracked by Wall St. Rank hold DCPH as of Q1 2021.

  • Amundi Asset Management US reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Amundi Asset Management US sold 5,200 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $297K.
  • Amundi Asset Management US first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • Amundi Asset Management US's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $311K in Q2 2020.
  • 168 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.